Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gianfranceschi

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Clinical Pharmacology and Therapeutics|June 1, 1989
Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranololC R Sirtori, B Johnson, V Vaccarino, et al.
Metabolism: Clinical and Experimental|February 1, 1993
Mechanisms of high-density lipoprotein reduction after probucol treatment: changes in plasma cholesterol esterification/transfer and lipase activitiesG Chiesa, S Michelagnoli, M Cassinotti, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1987
Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemiaC R Sirtori, G Franceschini, G Gianfranceschi, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridaemiaF Pazzucconi, L Mannucci, L Mussoni, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|October 1, 1994
Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass patternG Franceschini, M Cassinotti, G Vecchio, et al.
The American Journal of Clinical Nutrition|July 1, 1992
Olive oil, corn oil, and n-3 fatty acids differently affect lipids, lipoproteins, platelets, and superoxide formation in type II hypercholesterolemiaC R Sirtori, E Gatti, E Tremoli, et al.
Biotechnology Annual Review|October 12, 2005
Detection of metazoan species as a public health issue: simple methods for the validation of food safety and qualityO Vassioukovitch, M Orsini, A Paparini, et al.
The American Journal of Clinical Nutrition|March 1, 1995
Prolonged inhibition of platelet aggregation after n-3 fatty acid ethyl ester ingestion by healthy volunteersE Tremoli, P Maderna, F Marangoni, et al.
The American Journal of Clinical Nutrition|November 1, 1986
Controlled evaluation of fat intake in the Mediterranean diet: comparative activities of olive oil and corn oil on plasma lipids and platelets in high-risk patientsC R Sirtori, E Tremoli, E Gatti, et al.
Atherosclerosis|November 1, 1983
Clofibrate and tiadenol treatment in hyperlipoproteinemias. A comparative trial of drugs affecting lipoprotein catabolism and biosynthesisM Sirtori, G Montanari, G Gianfranceschi, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Clinical Pharmacology and Therapeutics|June 1, 1989
Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranololC R Sirtori, B Johnson, V Vaccarino, et al.
Metabolism: Clinical and Experimental|February 1, 1993
Mechanisms of high-density lipoprotein reduction after probucol treatment: changes in plasma cholesterol esterification/transfer and lipase activitiesG Chiesa, S Michelagnoli, M Cassinotti, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1987
Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemiaC R Sirtori, G Franceschini, G Gianfranceschi, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridaemiaF Pazzucconi, L Mannucci, L Mussoni, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|October 1, 1994
Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass patternG Franceschini, M Cassinotti, G Vecchio, et al.
The American Journal of Clinical Nutrition|July 1, 1992
Olive oil, corn oil, and n-3 fatty acids differently affect lipids, lipoproteins, platelets, and superoxide formation in type II hypercholesterolemiaC R Sirtori, E Gatti, E Tremoli, et al.
Biotechnology Annual Review|October 12, 2005
Detection of metazoan species as a public health issue: simple methods for the validation of food safety and qualityO Vassioukovitch, M Orsini, A Paparini, et al.
The American Journal of Clinical Nutrition|March 1, 1995
Prolonged inhibition of platelet aggregation after n-3 fatty acid ethyl ester ingestion by healthy volunteersE Tremoli, P Maderna, F Marangoni, et al.
The American Journal of Clinical Nutrition|November 1, 1986
Controlled evaluation of fat intake in the Mediterranean diet: comparative activities of olive oil and corn oil on plasma lipids and platelets in high-risk patientsC R Sirtori, E Tremoli, E Gatti, et al.
Atherosclerosis|November 1, 1983
Clofibrate and tiadenol treatment in hyperlipoproteinemias. A comparative trial of drugs affecting lipoprotein catabolism and biosynthesisM Sirtori, G Montanari, G Gianfranceschi, et al.
Pageof 6